Skip to main content

Beam Therapeutics Inc (BEAM) Stock

Beam Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Beam Therapeutics Inc (BEAM), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $25.25. Over the past 52 weeks, it has ranged between $13.53 and $35.25. This places the current price at 71.6% of its 52-week high and 86.6% above its 52-week low. Recent trading volume was recorded at 797,603. The 14-day Relative Strength Index (RSI) stands at 69.11, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $19.89 by 26.95%. Similarly, it is above its 200-day moving average of $21.52 by 17.33%. The MACD histogram is 0.10, indicating bullish momentum (MACD Line: 1.49, Signal Line: 1.39). There are currently 7 active alerts set for BEAM by users.

Market Cap

$2.44B

52-Week High

$35.25

-28.37% from high

52-Week Low

$13.53

+86.62% from low

Avg Daily Volume

2,332,544

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

2.22

EV/EBITDA

-7.03

EPS (TTM)

-$4.47

Price to Sales

40.50

Beta

2.15

More volatile than market

How is BEAM valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is BEAM's risk profile compared to the market?
With a beta of 2.15, Beam Therapeutics Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 21% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 2.22 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-1419.00%

Return on Equity

-41.90%

Return on Assets

-21.00%

Revenue Growth (YoY)

-28.10%

Earnings Growth (YoY)

0.00%

How profitable and efficient is BEAM's business model?
0 The operating margin of -1419.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -41.90% and ROA at -21.00%, the company achieves moderate returns on invested capital.
What are BEAM's recent growth trends?
Beam Therapeutics Inc's revenue declined by 28.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Shares Outstanding

101.16M

Book Value/Share

$10.70

Asset Type

Common Stock

What is BEAM's market capitalization and position?
Beam Therapeutics Inc has a market capitalization of $2.44B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 101.16M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does BEAM's price compare to its book value?
Beam Therapeutics Inc's book value per share is $10.70, while the current stock price is $25.25, resulting in a price-to-book (P/B) ratio of 2.36. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$46.42

83.84% upside potential

Analyst Recommendations

Strong Buy

2

Buy

11

Hold

2

Sell

0

Strong Sell

0

How reliable are analyst predictions for BEAM?
15 analysts cover BEAM with 87% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $46.42 implies 83.8% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on BEAM?
Current analyst recommendations:2 Strong Buy, 11 Buy, 2 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 3, 2025, 01:10 AM

Earnings Dates

Upcoming Earnings

Q3

Nov 10, 2025

Est. EPS: $-1.03

In 38 days

Recent Earnings History

DateQuarterEstimated EPSActual EPSSurprise
Aug 5, 2025Q2$-1.11$-1.00+9.9%
May 6, 2025Q1$-1.17$-1.24-6.0%
Feb 25, 2025Q4$-1.22$-1.09+10.3%
Nov 5, 2024Q3$-1.16$-1.17-0.9%
Aug 6, 2024Q2$-1.13$-1.11+1.8%
May 7, 2024Q1$-1.42$-1.21+14.8%
Feb 27, 2024Q4$-1.01$1.73+271.3%
Nov 8, 2023Q3$-1.36$-1.22+10.3%

Technical Indicators

RSI (14-day)

69.11

Neutral

50-Day Moving Average

$19.89

26.95% above MA-50

200-Day Moving Average

$21.52

17.33% above MA-200

MACD Line

1.49

MACD Signal

1.39

MACD Histogram

0.10

Bullish

What does BEAM's RSI value tell investors?
The RSI (Relative Strength Index) for BEAM is currently 69.11, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret BEAM's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.49 above the signal line at 1.39, with histogram at 0.10. This bullish crossover suggests upward momentum is building. The 50-day MA ($19.89) is below the 200-day MA ($21.52), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Oct 3, 2025, 01:10 AM

Active Alerts

Alert Condition
Remind me in
Threshold
90 days
Created
Oct 3, 2025, 01:56 AM
Alert Condition
Price falls below
Threshold
$20.00
Created
Oct 3, 2025, 01:56 AM
Alert Condition
Price rises above
Threshold
$28.00
Created
Oct 3, 2025, 01:56 AM
Alert Condition
Volume change
Threshold
150%
Created
Oct 3, 2025, 01:56 AM
Alert Condition
MA Breakout (Bearish)
Threshold
50 days
Created
Oct 3, 2025, 01:56 AM
Alert Condition
MA Breakout (Bearish)
Threshold
200 days
Created
Oct 3, 2025, 01:10 AM
Alert Condition
RSI Threshold Cross
Threshold
55
Created
Oct 3, 2025, 01:10 AM

Stay Ahead of the Market with Beam Therapeutics Inc Alerts

Set up price alerts for Beam Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.